Multiple Sclerosis and the Evolution of its Treatments

Main Article Content

Vania Nayeli Martínez Valladolid
Frida Sofía Sánchez Hernández
Moisés Aguilar Farias
Ingrid Pamela Rodríguez Minguela
Miguel Ángel Bonaparte Pimentel
Zuleyka Roxana Martinez Martínez
Nancy Jaime Toledo
Jesús Iván Jaime Toledo

Abstract

Multiple sclerosis is an autoimmune disease that demyelinates the nerves, the damage to the nerves interrupts communication between the brain and the body. Although it is a disease that has no cure, it has been studied for a long time to try to find a treatment to stop the progression of the disease. Currently there are many drugs that can help reduce the effects caused by the disease, but it is necessary to evaluate which one is given because of the adverse effects that these may have, even so, the research of new treatments has not stopped until finding one that benefits completely or its risks are minimal.

Article Details

How to Cite
Vania Nayeli Martínez Valladolid, Frida Sofía Sánchez Hernández, Moisés Aguilar Farias, Ingrid Pamela Rodríguez Minguela, Miguel Ángel Bonaparte Pimentel, Zuleyka Roxana Martinez Martínez, Nancy Jaime Toledo, & Jesús Iván Jaime Toledo. (2023). Multiple Sclerosis and the Evolution of its Treatments. International Journal of Medical Science and Clinical Research Studies, 3(06), 1163–1168. https://doi.org/10.47191/ijmscrs/v3-i6-25
Section
Articles

References

I. Cree, B. A., & Hauser, S. L. (2016). GSU digital library. Retrieved from AccessMedicine https://bibliodig.uag.mx:2074/content.aspx?sectionid=267807982&bookid=31 18&Resultcli ck=2

II. Fernandez, J. (March 31, 2022). Baptist Health South Florida. Retrieved from https://baptisthealth.net/baptist-health-news/es/la-esclerosis-multiple-los-ava nces-in-therapies-and-research-can-reduce-the-progression-of-the-e m-and-potentially-prevent-disease/

III. García, C. C. (August 29, 2022). Government of Mexico. Retrieved from

https://www.gob.mx/imss/articulos/esclerosis-multiple-la-enfermedad-de-las- mil-caras

IV. Marínez-Altarriba, M. (September 2015). Elsevier. Retrieved from Medicina de Medicina deFamilia. SEMERGEN: https://www.elsevier.es/es-revista-medicina-familia-semergen-40-articulo-revision-esclerosis-multiple-2-diagnostico-S1138359314003256

V. Torres, P. C. (2015). Special communication in neurology. Retrieved from

http://www.scielo.org.co/pdf/anco/v31n1/v31n1a17.pdf

VI. Darwin R, (2019).Clinical Practice Guideline for the Diagnosis and Treatment of Multiple Sclerosis in Adults.https://doi.org/10.20453/rnp.v82i4.3646

VII. .Boullosa-Lale S, González-Freire L, Martínez-Martínez L, Crespo-Diz C. Safety and persistence of dimethyl fumarate as a treatment for relapsing-remitting multiple sclerosis. Farm Hosp. 2021;45(2):73-6. DOI: 10.7399/fh.11567.

VIII. .López Gutiérrez, C.R., Castrillón Taba, M., & Lopera Vásquez, J.P. (2022). Effect of a neuropsychological rehabilitation program of executive functions in a case of multiple sclerosis. Rev. CES Psico, 15(3), 97-114.

https://dx.doi.org/10.21615/cesp.6104

IX. .Karen Whalen (2016). Pharmacology, sixth edition, wolters Kluwer publishing house.

X. Arteaga-Noriega A. (2020) Symptomatological treatment of multiple sclerosis. Revistaavft.com. Available at:

https://www.revistaavft.com/images/revistas/2020/avft_2_2020/1_trataiento_s intomatol%C3%B3gico.pdf.

XI. Mrabet, S., Wafa, M., & Giovannoni, G. (2022). Multiple sclerosis and migraine: Links, management and implications. Multiple Sclerosis and Related Disorders, 68(104152), 104152. https://doi.org/10.1016/j.msard.2022.104152.

XII. Kyriakatis, G. M., Besios, T., & Lykou, P. M. (2022). The effect of therapeutic exercise on depressive symptoms in people with multiple sclerosis - A systematic review. Multiple Sclerosis and Related Disorders, 68(104407), 104407. https://doi.org/10.1016/j.msard.2022.104407.

XIII. Harrison. Principles of Internal Medicine, 21e. (2022). Mhmedical.com. Retrieved April 19, 2023, from https://accessmedicina.mhmedical.com/book.aspx?bookID=3118

Most read articles by the same author(s)